Needham Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Needham analyst Matthew Shea reiterated a Buy rating on Privia Health Group (PRVA – Research Report) today and set a price target of $30.00.
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Olema Pharmaceuticals (OLMA) and Privia Health Group (PRVA)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Caribou Biosciences (CRBU – Research Report), ...
ABC News2d
Political News
Immigration lawyer Francisco Symphorien-Saavedra explains the importance of an appeals court set to weigh President Donald Trump's use of the Alien Enemies Act. The second lady’s office says she ...